CS232735B2 - Method of making cephalosporine derivatives - Google Patents

Method of making cephalosporine derivatives Download PDF

Info

Publication number
CS232735B2
CS232735B2 CS826505A CS650582A CS232735B2 CS 232735 B2 CS232735 B2 CS 232735B2 CS 826505 A CS826505 A CS 826505A CS 650582 A CS650582 A CS 650582A CS 232735 B2 CS232735 B2 CS 232735B2
Authority
CS
Czechoslovakia
Prior art keywords
group
formula
thieno
pyridinium
cephem
Prior art date
Application number
CS826505A
Other languages
Czech (cs)
English (en)
Other versions
CS650582A2 (en
Inventor
William H W Lunn
Robert T Vasileff
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS650582A2 publication Critical patent/CS650582A2/cs
Publication of CS232735B2 publication Critical patent/CS232735B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CS826505A 1981-09-08 1982-09-08 Method of making cephalosporine derivatives CS232735B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30035781A 1981-09-08 1981-09-08
US34062882A 1982-01-19 1982-01-19

Publications (2)

Publication Number Publication Date
CS650582A2 CS650582A2 (en) 1984-06-18
CS232735B2 true CS232735B2 (en) 1985-02-14

Family

ID=26971737

Family Applications (1)

Application Number Title Priority Date Filing Date
CS826505A CS232735B2 (en) 1981-09-08 1982-09-08 Method of making cephalosporine derivatives

Country Status (17)

Country Link
EP (1) EP0074268A3 (xx)
KR (1) KR840001585A (xx)
CS (1) CS232735B2 (xx)
DD (1) DD209633A5 (xx)
DK (1) DK399282A (xx)
ES (2) ES8404361A1 (xx)
FI (1) FI823088L (xx)
GB (1) GB2105719A (xx)
GR (1) GR76701B (xx)
HU (1) HU187575B (xx)
IL (1) IL66726A0 (xx)
NZ (1) NZ201833A (xx)
PH (1) PH19756A (xx)
PL (1) PL238158A1 (xx)
PT (1) PT75518B (xx)
RO (1) RO84456B (xx)
SU (1) SU1169542A3 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374410D1 (en) * 1982-06-28 1987-12-17 Bristol Myers Co Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
US4480098A (en) * 1982-11-12 1984-10-30 Eli Lilly And Company Preparation of alkali metal thieno(furo)pyridines
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
EP0137442A3 (de) * 1983-10-08 1986-01-15 Hoechst Aktiengesellschaft Cephalosporinderivate und Verfahren zu ihrer Herstellung
ZA847926B (en) * 1983-10-17 1986-05-28 Lilly Co Eli 3-bicyclicpyridinium-methyl cephalosporins
US4868173A (en) * 1984-11-20 1989-09-19 Ici Pharma Cephalosporin derivatives
EP0187456A1 (en) * 1984-11-29 1986-07-16 Ici Pharma Cephalosporin derivatives
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
GB8626245D0 (en) * 1985-11-27 1986-12-03 Ici Pharma Cephalosporin compounds
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
US4918067A (en) * 1986-07-24 1990-04-17 Beecham Group P.L.C. Heterocyclic substituted penicillin antibiotics
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
JP2003522763A (ja) * 2000-02-10 2003-07-29 ファルマシア・アンド・アップジョン・カンパニー ピペラジンアミド置換基を持つオキサゾリジノンチオアミド
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
EP1618114B1 (en) 2003-04-16 2010-07-14 Sandoz AG Processes for the preparations of cefepime
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
FR2440738A1 (fr) * 1978-11-13 1980-06-06 Parcor Medicament a base de derives des thieno (2,3-c) et (3,2-c) pyridines
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"

Also Published As

Publication number Publication date
DD209633A5 (de) 1984-05-16
KR840001585A (ko) 1984-05-07
ES527763A0 (es) 1985-05-16
ES8505374A1 (es) 1985-05-16
PT75518B (en) 1985-11-12
ES515548A0 (es) 1984-04-16
ES8404361A1 (es) 1984-04-16
RO84456B (ro) 1984-08-30
FI823088L (fi) 1983-03-09
GB2105719A (en) 1983-03-30
EP0074268A3 (en) 1984-05-23
RO84456A (ro) 1984-06-21
GR76701B (xx) 1984-08-29
CS650582A2 (en) 1984-06-18
PL238158A1 (en) 1984-11-19
SU1169542A3 (ru) 1985-07-23
HU187575B (en) 1986-01-28
IL66726A0 (en) 1982-12-31
NZ201833A (en) 1985-09-13
DK399282A (da) 1983-03-09
PT75518A (en) 1982-10-01
FI823088A0 (fi) 1982-09-07
EP0074268A2 (en) 1983-03-16
PH19756A (en) 1986-06-26

Similar Documents

Publication Publication Date Title
CS232735B2 (en) Method of making cephalosporine derivatives
US4396620A (en) Cephalosporin quinolinium betaines
NO155347B (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt (6r,7r)-7-((z)-2-(2-amino-tiazol-4-yl)-2-(2-karboksy-prop-2-oksyimino)-acetamido)-3-(1-pyridiniummetyl)cef-3-em-4-karboksylat.
US4396619A (en) Cephalosporin betaines
CA1225390A (en) 3-bicyclicpyridinium-methyl cephalosporins
US4692443A (en) 3-bicyclicpyridinium-methyl cephalosporins
KR920004820B1 (ko) 새로운 세팔로스포린 유도체의 제조방법
US4501739A (en) Thieno and furopyridinium-substituted cephalosporins
US4401668A (en) Pyrazinium substituted cephalosporins
US4406898A (en) Oxazole and oxadiazole cephalosporins
US5202315A (en) Cephalosporin compounds
US4577014A (en) Thieno and furopyridinium-substituted cephalosporins
US5329002A (en) Antibacterial cephalosporin compounds
US4748172A (en) 3-bicyclicpyridinium-methyl cephalosporins
JPH0228185A (ja) セファロスポリン化合物及びその合成中間体
US4382931A (en) 3'-Substituted quinolinium cephalosporins
US4665066A (en) 3-thiazolomethyl cephalosporins as antibiotics
EP0508375A2 (en) Novel cephalosporin compounds and processes for preparation thereof
EP0349340B1 (en) Novel cephem compound, method for producing the same and anti-bacterial agent
US4980464A (en) Method for production of cephalosporin compounds
CA2053456C (en) Novel cephem compounds, their preparation processes and antibacterial agents
JPS62158282A (ja) １−カルバセフアロスポリン抗生物質
JP2002514650A (ja) 新規なセファロスポリン化合物、その製造方法およびそれを含有する抗菌性組成物
US4857521A (en) Trialkylsilyl pyridinium cephalosporin antibiotics
EP0018155A2 (en) Novel cephalosporin compounds, a process for the preparation thereof, pharmaceutical compositions containing the same and the use thereof as a therapeutic agent against a microorganism